Ketamine Trial for Suicidal Patients
Phase 1
50
about 2 years
18–65
2 sites in KS
What this study is about
This trial is testing if low-dose intravenous ketamine can be safely used in the Emergency Department to help people with suicidal thoughts. The goal is to determine whether this treatment is safe and feasible.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ketamine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ketamine (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
Primary: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Secondary: Hospital Length of Stay
Psychiatry / Mental Health